Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
243
-
Total 13F shares, excl. options
-
61.6M
-
Shares change
-
-2.05M
-
Total reported value, excl. options
-
$1.89B
-
Value change
-
-$41.5M
-
Put/Call ratio
-
0.17
-
Number of buys
-
155
-
Number of sells
-
-88
-
Price
-
$30.67
Significant Holders of GENMAB A/S - SPONSORED ADS (GMAB) as of Q3 2025
276 filings reported holding GMAB - GENMAB A/S - SPONSORED ADS as of Q3 2025.
GENMAB A/S - SPONSORED ADS (GMAB) has 243 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.6M shares
.
Largest 10 shareholders include Orbis Allan Gray Ltd (11.1M shares), ALLIANCEBERNSTEIN L.P. (11M shares), Paradigm Biocapital Advisors LP (3.82M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (3.64M shares), HARDING LOEVNER LP (3.48M shares), BlackRock, Inc. (3.45M shares), RENAISSANCE TECHNOLOGIES LLC (2.82M shares), FIRST TRUST ADVISORS LP (1.69M shares), MORGAN STANLEY (1.67M shares), and TWO SIGMA ADVISERS, LP (1.43M shares).
This table shows the top 243 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.